Bird Rock Bio's Debt Round

Bird Rock Bio raised a round of funding on June 11, 2014. Investors include Silicon Valley Bank.

Bird Rock Bio, formerly RuiYi, is a clinical stage biopharmaceutical company focused on developing immuno-inflammatory regulators. The company's strategy leverages biologic targets with substantial hu…

Articles about Bird Rock Bio's Debt Round: